Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 23% ± 5% | |
GABAergic neuron | 4 studies | 27% ± 7% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 7% | |
endothelial cell | 3 studies | 23% ± 8% | |
basal cell | 3 studies | 40% ± 28% | |
glutamatergic neuron | 3 studies | 40% ± 6% | |
transit amplifying cell | 3 studies | 24% ± 5% | |
oligodendrocyte | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2585.19 | 245 / 245 | 100% | 35.11 | 502 / 502 |
stomach | 100% | 1651.98 | 359 / 359 | 100% | 27.89 | 286 / 286 |
esophagus | 100% | 1909.85 | 1444 / 1445 | 100% | 27.95 | 183 / 183 |
breast | 100% | 2527.54 | 459 / 459 | 100% | 38.23 | 1116 / 1118 |
intestine | 100% | 2430.56 | 966 / 966 | 100% | 27.86 | 526 / 527 |
bladder | 100% | 2374.86 | 21 / 21 | 100% | 25.10 | 502 / 504 |
uterus | 100% | 3423.04 | 170 / 170 | 100% | 25.44 | 457 / 459 |
lung | 100% | 2199.86 | 576 / 578 | 100% | 27.25 | 1153 / 1155 |
thymus | 100% | 2424.23 | 653 / 653 | 99% | 25.71 | 601 / 605 |
ovary | 100% | 4398.70 | 180 / 180 | 99% | 22.80 | 427 / 430 |
brain | 99% | 1693.25 | 2617 / 2642 | 100% | 36.09 | 705 / 705 |
adrenal gland | 100% | 1723.99 | 258 / 258 | 99% | 27.15 | 227 / 230 |
pancreas | 100% | 1478.40 | 327 / 328 | 98% | 22.79 | 175 / 178 |
skin | 100% | 2851.94 | 1809 / 1809 | 98% | 37.06 | 462 / 472 |
kidney | 100% | 1699.70 | 89 / 89 | 97% | 19.40 | 871 / 901 |
liver | 91% | 569.18 | 206 / 226 | 62% | 8.92 | 251 / 406 |
adipose | 100% | 2172.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2055.15 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.05 | 29 / 29 |
spleen | 100% | 2112.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.17 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.26 | 1 / 1 |
muscle | 98% | 1131.09 | 790 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 24.48 | 78 / 80 |
heart | 97% | 1258.42 | 839 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 65% | 1076.27 | 602 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0005654 | Cellular component | nucleoplasm |
GO_0080008 | Cellular component | Cul4-RING E3 ubiquitin ligase complex |
GO_0005515 | Molecular function | protein binding |
Gene name | DCAF16 |
Protein name | DDB1- and CUL4-associated factor 16 |
Synonyms | C4orf30 |
Description | FUNCTION: Functions as a substrate recognition component for CUL4-DDB1 E3 ubiquitin-protein ligase complex, which mediates ubiquitination and proteasome-dependent degradation of nuclear proteins. . |
Accessions | Q9NXF7 ENST00000382247.6 |